Will New Environmental Concerns Weigh on Canadian Marijuana Stocks?

Hydropothecary Corp (TSX:HEXO) is ahead of the curve when it comes to new environmental concerns that may impact the legal cannabis industry.

| More on:

Just when you thought that Canadian weed stocks were confusing enough, a new consideration comes along to potentially spook the market.

The Globe and Mail ran a story on Monday that quoted Werner Antweiler of the University of British Columbia, as he voiced his concerns about the impact of the legal marijuana industry’s potential carbon footprint.

I’ll skip the facts and figures from the article and focus on two things that it brings up: firstly, the idea that government regulations covering weed production are likely to be applied once results start to come in regarding the industry’s use of resources; and secondly, a well-known producer seems to be ahead of the curve.

Energy and water consumption may hit weed’s bottom line

Intensified cannabis farming is likely to use up vast amounts of electricity and water. In fact, cannabis growing on large a scale is expected to weigh more heavily on resources than the wine industry does.

This is fine in times of higher water availability, but consider the impacts on the cannabis industry of a drought or a particularly dark summer: the former hitting production levels through water shortages, and the latter requiring more lighting during daylight hours.

Such impacts on resources will have a knock-on effect for the environment and come at a time when climate change is one of the hottest topics of our age, both politically and economically.

Meet weed’s first poster child for environmental responsibility

One company seen to being doing its best on the climate front is Hydropothecary (TSX:HEXO). Its greenhouses reduce the need for electric lighting during long summer days, while computerized irrigation systems dole out the exact amount of water needed for growth, reducing waste.

Overvalued by twice its future cash flow value, Hydropothecary stock is in high demand with a share price to match. Since it’s still in loss-making mode, value investors will have to skip the P/E and PEG ratios and look to a P/B of 2.9 times book. If that sounds a little steep, consider that the pharma sector average is four times book.

Growth investors looking for plenty of green will love Hydropothecary’s nice and heady 156.9% expected annual growth in earnings. Momentum investors eyeing that ever-rising share price will no doubt be similarly pleased.

Brand-conscious investors will have been encouraged by Hydropothecary’s brand-new deal with Molson Coors Canada to make a range of non-alcoholic cannabis drinks, making this a perfect first time buy for new investors who like to be familiar with a ticker as a real-world entity before buying.

The bottom line

Green investing may not be a big deal at present for Canadian shareholders, but real-world considerations when it comes to the cannabis industry’s impact on climate change could spill over into actual fiscal concerns.

Once regulations are applied that cover water and energy consumption, cannabis producers may see legal stipulations begin to impact net worth. This, likewise, could impact their investors’ long-term capital gains. On the flip side, companies seen to be greener than their competition may see benefits to their public image and subsequently to their share price as well.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Investing

Canada national flag waving in wind on clear day
Tech Stocks

Trump Trade: Canadian Stocks to Watch

With Trump returning to the presidency, there are some sectors that could boom in Canada, and others to watch. But…

Read more »

A train passes Morant's curve in Banff National Park in the Canadian Rockies.
Investing

Is Canadian National Railway Worth Buying for its 2.2% Dividend Yield?

Let's dive into whether Canadian National Railway (TSX:CNR) is a top buy for long-term investors at this point in the…

Read more »

nuclear power plant
Energy Stocks

Is Cameco Stock Still a Buy?

Cameco stock recently reported earnings that showed the Westinghouse investment is creating some major costs. But that could change.

Read more »

cloud computing
Dividend Stocks

Insurance Showdown: Better Buy, Great-West Life or Manulife Stock?

GWO stock and MFC stock are two of the top names in insurance, but which holds the better outlook?

Read more »

analyze data
Dividend Stocks

Here’s Why the Average TFSA for Canadians Aged 41 Isn’t Enough

The average TFSA simply isn't enough for most Canadians in their early 40s. Here's how to catch up.

Read more »

A plant grows from coins.
Dividend Stocks

The Smartest Dividend-Growth Stocks to Buy With $1,000 Right Now

New dividend-growth investors should consider CN Rail (TSX:CNR) stock and another top play if they're looking to build wealth over…

Read more »

concept of real estate evaluation
Dividend Stocks

How to Earn a TFSA Paycheque Every Month and Pay No Taxes on It

Canadian REITs can turn your TFSA into a monthly paycheque machine for life. Here's how Morguard North American Residential REIT…

Read more »

Start line on the highway
Investing

2 No-Brainer Growth Stocks to Buy Now With $5,000 and Hold Long Term

Market conditions today are ideal for growth investing, and two rising stocks are no-brainer buys in November.

Read more »